These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23920356)

  • 41. Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients.
    Nangaku M; Mimura I; Yamaguchi J; Higashijima Y; Wada T; Tanaka T
    J Ren Nutr; 2015 Mar; 25(2):160-3. PubMed ID: 25556149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
    Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats.
    Paterno JC; Bergamaschi CT; Campos RR; Higa EM; Soares MF; Schor N; Freire AO; Teixeira VP
    Kidney Blood Press Res; 2012; 35(5):355-64. PubMed ID: 22473039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 2'-phosphophloretin on renal function in chronic renal failure rats.
    Peerce BE; Weaver L; Clarke RD
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F48-56. PubMed ID: 14761861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.
    Hoibian E; Florens N; Koppe L; Vidal H; Soulage CO
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac remodeling associated with protein increase and lipid accumulation in early-stage chronic kidney disease in rats.
    Kuwahara M; Bannai K; Segawa H; Miyamoto K; Yamato H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1433-43. PubMed ID: 24798235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased fluoride content in the femur growth plate and cortical bone of uremic rats.
    Mathias RS; Amin U; Mathews CH; Denbesten P
    Pediatr Nephrol; 2000 Sep; 14(10-11):935-9. PubMed ID: 10975302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Biomechanical Testing for the Assessment of Bone Quality in an Experimental Model of Chronic Kidney Disease.
    Oksztulska-Kolanek E; Znorko B; Michałowska M; Pawlak K
    Nephron; 2016; 132(1):51-8. PubMed ID: 26680019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
    Kuwahara M; Inoshita S; Terada Y; Sasaki S
    Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone pain in dialysis patients is not associated with bone mineral density but with serum concentration of small uremic toxins.
    Grzegorzewska AE; Młot-Michalska M
    Adv Med Sci; 2007; 52():228-31. PubMed ID: 18217423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone.
    Akkus O; Adar F; Schaffler MB
    Bone; 2004 Mar; 34(3):443-53. PubMed ID: 15003792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease.
    Pawlak D; Oksztulska-Kolanek E; Znorko B; Domaniewski T; Rogalska J; Roszczenko A; Brzóska MM; Pryczynicz A; Kemona A; Pawlak K
    PLoS One; 2016; 11(10):e0163526. PubMed ID: 27711209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
    Watanabe K; Watanabe T; Nakayama M
    Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats.
    Yoshifuji A; Wakino S; Irie J; Matsui A; Hasegawa K; Tokuyama H; Hayashi K; Itoh H
    Clin Exp Nephrol; 2018 Oct; 22(5):1069-1078. PubMed ID: 29675795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.
    Yoshifuji A; Wakino S; Irie J; Tajima T; Hasegawa K; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2016 Mar; 31(3):401-12. PubMed ID: 26487672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
    Mishima E; Fukuda S; Kanemitsu Y; Saigusa D; Mukawa C; Asaji K; Matsumoto Y; Tsukamoto H; Tachikawa T; Tsukimi T; Fukuda NN; Ho HJ; Kikuchi K; Suzuki C; Nanto F; Suzuki T; Ito S; Soga T; Tomioka Y; Abe T
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F824-F833. PubMed ID: 29167170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.